Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors.

Autor: Lieske, Nora V.¹, Tonby, Kristian^2,3, Kvale, Dag^2,3,4, Dyrhol-Riise, Anne M.^2,3,4, Tasken, Kjetil^1,3,4,5 kjetil.tasken@ncmm.uio.no

Publikováno v: PLoS ONE. 11/6/2015, Vol. 10 Issue 10, p1-19. 19p.

Targeting tuberculosis and HIV infection-specific regulatory T cells with MEK/ERK signaling pathway inhibitors

Autor: Lieske, Nora Valeska, Tonby, Kristian, Kvale, Dag, Dyrhol-Riise, Anne Ma, Tasken, Kjetil

Publikováno v: Lieske, Nora Valeska Tonby, Kristian Kvale, Dag Dyrhol-Riise, Anne Ma Tasken, Kjetil . Targeting tuberculosis and HIV infection-specific regulatory T cells with MEK/ERK signaling pathway inhibitors. PLoS ONE. 2015, 10:e0141903(11)
PLoS ONE

Externí odkaz: http://hdl.handle.net/10852/56774
https://www.duo.uio.no/bitstream/handle/10852/56774/1/journal.pone.0141903.PDF

LB11 - New dynabeads™treg CD3/CD28 and animal origin-free, serum-free media for regulatory T cell activation and expansion to be used in clinical applications

Autor: Bernstroem, Kerstin E., Zhang, Hui, Torres-Castillo, Maria, Lieske, Nora, Økern, Grethe, Schroder, Ida Caroline, Herreng, Tuva Holt, Almåsbak, Hilde, Varela-Rohena, Angel, Aarvak, Tanja

Publikováno v: In Cytotherapy May 2017 19(5) Supplement:e6-e6

Human regulatory T cells control TCR signaling and susceptibility to suppression in CD4+T cells

Autor: Chellappa, Stalin, Lieske, Nora V., Hagness, Morten, Line, Pål D., Taskén, Kjetil, Aandahl, Einar M.

Publikováno v: Journal of Leukocyte Biology; July 2016, Vol. 100 Issue: 1 p5-16, 12p

The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection.

Autor: Tonby K; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. kristian.tonby@medisin.uio.no.; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway. kristian.tonby@medisin.uio.no., Wergeland I; Department of Clinical Science, University of Bergen, Bergen, Norway., Lieske NV; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway., Kvale D; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway., Tasken K; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway.; K.G. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway.; Biotechnology Centre, University of Oslo, Oslo, Norway., Dyrhol-Riise AM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.; K.G. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2016 Oct 24; Vol. 16 (1), pp. 599. Date of Electronic Publication: 2016 Oct 24.